🇮🇳IN
Sign In
VI

VISTAPH

BSE

Vista Pharmaceuticals Ltd

₹6.47

+0.30(+4.86%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

VISTAPH financial summary

For Mar 2026, Vista Pharmaceuticals Ltd reported revenue of ₹5 crore, which fell 50.0% from the previous year. Net profit was -₹12 crore, on an operating margin of -271%. Earnings per share came in at -₹1.96. Over the 5 years from Mar 2021 to Mar 2026, revenue changed at a compound annual rate of 38.0%. The highest operating margin in that period was -33% in Mar 2024. Annual results are available for 12 financial years, from Mar 2015 to Mar 2026.

Revenue₹5 crore
Net profit-₹12 crore
Operating margin-271%
EPS-₹1.96

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer